Advertisement

Ads Placeholder
Loading...

CSL Limited

CSLLY•PNK
Healthcare
Biotechnology
$24.98
$-0.15(-0.60%)
U.S. Market opens in 12h 2m

CSL Limited (CSLLY) Stock Overview

Explore CSL Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap96.9B
P/E Ratio67.45
EPS (TTM)$1.54
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$18.33
3 Months$43.73
1 Year Target$34.67

CSLLY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CSL Limited (CSLLY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 30.23, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $34.67.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 67.45 and a market capitalization of 96.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.44%
5-Day Change
6.24%
1-Month Change
-2.80%
3-Month Change
-14.52%
6-Month Change
-26.28%
Year-to-Date (YTD) Change
-13.00%
1-Year Change
-35.83%
3-Year Change
-50.06%
5-Year Change
-50.38%
All-Time (Max) Change
338.95%

Contact Information

https://www.csl.com.au
61 3 9389 1911
45 Poplar Road, Melbourne, VIC, 3052

Company Facts

326,980 Employees
IPO DateDec 29, 2009
CountryAU
Actively Trading

Frequently Asked Questions